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Abstract
Background: Over the past 16 years, sepsis management has been guided by large-volume fluid administration to
achieve certain hemodynamic optimization as advocated in the Rivers protocol. However, the safety of such
practice has been questioned because large-volume fluid administration is associated with fluid overload and
carries the worst outcome in patients with sepsis. Researchers in multiple studies have declared that using less fluid
leads to increased survival, but they did not describe how to administer fluids in a timely and appropriate manner.
Case presentation: An 86-year-old previously healthy Sundanese man was admitted to the intensive care unit at
our institution with septic shock, acute kidney injury, and respiratory distress. Standard care was implemented
during his initial care in the high-care unit; nevertheless, his condition worsened, and he was transferred to the
intensive care unit. We describe the timing of fluid administration and elaborate on the amount of fluids needed
using a conservative fluid regimen in a continuum of resuscitated sepsis.
Conclusions: Because fluid depletion in septic shock is caused by capillary leak and pathologic vasoplegia,
continuation of fluid administration will drive intravascular fluid into the interstitial space, thereby producing
marked tissue edema and disrupting vital oxygenation. Thus, fluids have the power to heal or kill. Therefore,
management of patients with sepsis should entail early vasopressors with adequate fluid resuscitation followed by
a conservative fluid regimen.
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Background
Fluid administration has been a topic of interest since
the development of aggressive fluid resuscitation by the
2003 Surviving Sepsis Campaign [1]. Although it is be-
lieved that fluids play a vital part in sepsis management,
recent studies of large-volume fluid administration have
shown conflicting results. Authors of a systematic review
on fluids in critically ill and injured patients reported data
derived from 19,902 subjects to be conclusive regarding
the harm of positive fluid balance. Patients with a positive
cumulative balance of 6982 ± 5629 ml have a higher mor-
tality rate than those patients with an overall cumulative
fluid balance of 2449 ± 2965 ml by day 7 (24.7% vs. 33.2%,
OR 0.42, 95% CI 0.32–0.55, p < 0.0001) [2].
Administration of intravenous fluid remains one of the
most common therapies given to hospitalized patients;
however, studies have shown that up to 20% of these pa-
tients are given inappropriate fluid therapy [3]. As subtle
as it seems, fluid therapy is a double-edged sword that
carries the potential either to reverse organ damage or
to cause irreversible damage. Fluid resuscitation at the
early stages of shock is necessary to reverse life-
threatening conditions, but what happens after this stage
has passed? Should fluid resuscitation be continued, or
should fluids start to be tapered? Surely, fluid therapy
cannot be applied as a one-size-fits-all solution.
With new insights into fluid administration and
clinical outcome, perhaps the use of large-volume fluid
resuscitation in the management of patients with sepsis
ought to be reconsidered. How much fluid is needed in
what amount of time, and what are the parameters for
monitoring a safe and adequate fluid balance? In a re-
view on intravenous fluid therapy, Hoste et al. divided
fluid administration into four phases: resuscitation,
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optimization, stabilization, and evacuation (ROSE) [3].
In this case report, we describe the use of ROSE fluid
management along with parameters for monitoring a
safe and adequate fluid balance throughout the develop-
ment of sepsis.
Case presentation
A previously healthy 86-year-old Sundanese man with
no comorbidities was admitted to the general ward of
our hospital with excruciating pain in his right hip and
knee after a prior fall. Our patient weighed 65 kg and
was 165 cm tall. On admission, he was fully alert, and
the results of his radiologic investigations were normal.
Intravenous analgesics and nerve blocks were adminis-
tered, and the patient remained hospitalized for 12 days
of nursing care. On the 12th day, intravenous catheter
site induration and redness developed, which rapidly
progressed to necrotic and pustular tissue formation
within 12 h (Fig. 1). A wound culture was taken, and
intravenous antibiotic therapy was promptly initiated;
nevertheless, the patient’s condition worsened on day 14
of his hospitalization, and he became lethargic.
Our patient was moved to the high-care unit (HCU)
with the following hemodynamic parameters: blood
pressure 107/46 mmHg, mean arterial pressure (MAP)
66 mmHg, heart rate 88 beats per minute (bpm), re-
spiratory rate 21 breaths per minute, and oxygen satur-
ation 100% through a 5-L nasal cannula. He remained
afebrile. A complete blood examination revealed
hemoglobin (Hgb) 1.94 g/dl (reference range 11.70–15.50
g/dl), hematocrit (Hct) 32.35% (reference range 35.00–
47.00%), white blood cell count (WBC) 20,550/mm3 (ref-
erence range 3600–11,000/mm3), platelets (Plt) 137,700/μl
(reference range 150,000–440,000/μl), C-reactive protein
199.90 mg/L (reference range 0.00–3.00 mg/L), and
procalcitonin (PCT) 37.00 ng/ml (reference range <0.5
ng/ml). Other levels recorded were alanine aminotransfer-
ase 13 U/L (reference range 0–55 U/L), aspartate trans-
aminase 12 U/L (reference range 5–34 U/L), urea 126.0
mg/dl (reference range <50 mg/dl), creatinine 2.42 mg/dl
(reference range 0.5–1.1 mg/dl), Na+ 131 mEq/L
(reference range 135–145 mEq/L), K+ 6.2 mEq/L (refer-
ence range 3.5–5 mEq/L), Cl− 101 mEq/L (reference range
96–110 mEq/L), and random blood glucose 114 mg/dl.
A diagnosis of necrotizing fasciitis with sepsis, stage 2
acute kidney injury, and hyperkalemia was made. One
gram of intravenous cefoperazone twice daily and 400
mg of moxifloxacin once daily were given. The patient’s
hyperkalemia was treated using 25 U of insulin and 100
ml of 40% dextrose solution for 2 h. A nasogastric tube
was inserted, and the patient’s stomach was decom-
pressed. A central venous catheter was inserted, and cul-
tures from blood, urine, and sputum were taken.
Nevertheless, the patient’s condition worsened. He be-
came unresponsive with a respiratory rate of 38 breaths
per minute and prominent use of accessory muscles. His
oxygen saturation was 88% with a 15-L non-rebreathing
mask; his central venous pressure (CVP) was 5 mmHg;
his blood pressure was 90/60 mmHg (MAP 70 mmHg);
and he had an electrocardiographic reading of atrial
fibrillation with rapid ventricular response and a heart
rate of 140–160 bpm. Arterial blood gas analysis re-
vealed respiratory acidosis with pH 7.029, partial pres-
sure of carbon dioxide (pCO2) 77.9 mmHg, partial
pressure of oxygen (pO2) 94 mmHg, HCO3
− 20.9 mEq/L,
base excess −10 mEq/L, and serum lactate 3.3 mmol/L
(reference range <0.6–2.2 mmol/L). The patient’s blood
pressure continued to fall and reached 60/30 mmHg
(MAP 40 mmHg), followed by multiple episodes of
bradycardia from 140 bpm to 70 bpm despite adminis-
tration of 500 ml of colloid and 100 ml of 20% albumin.
Hence, noradrenaline at 0.5 μg/kg/minute and dobuta-
mine at 10 μg/kg/minute were initiated. In the HCU, the
patient received a total fluid input of 4644 ml with urine
output of 55 ml/h and fluid balance of +3540 ml/20 h.
The patient was promptly transferred to the intensive
care unit (ICU), where he was intubated and mechanic-
ally ventilated. He was placed on adaptive support venti-
lation mode with a positive end-expiratory pressure of 5
cmH2O and a fraction of inspired oxygen of 0.5. At this
time, his blood pressure plummeted to 80/50 mmHg
(MAP 60 mmHg), and his CVP was 16 mmHg.
Noradrenaline was increased to 0.8 μg/kg/minute and
dobutamine to 3 μg/kg/minute, to which he responded.
His blood pressure was maintained at 115/60 mmHg
(MAP 78 mmHg); his heart rate was 110–120 bpm; and
his CVP was 12 mmHg. Two hours postintubation, his
blood gas analysis revealed pH 7.28, pCO2 39.6 mmHg,
pO2 112.5 mmHg, HCO3
− 19.1 mEq/L, base excess −6.9
mEq/L, and a lactate level decreasing to 2.27 mmol/L. A
Fig. 1 Necrotic and pustular tissue formation on the right arm upon
intensive care unit admission
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chest x-ray revealed patchy infiltrates on the lower lung
regions with a cardiothoracic ratio of 61% (Fig. 2), and
echocardiography revealed an ejection fraction of 67%
with no ventricular wall motion abnormalities.
Continuous analgesia and sedation with morphine and
midazolam infusion were administered, and the patient’s
vital signs stabilized. A repeat blood workup revealed
insignificant changes except for urea and creatinine in-
creasing to 159.5 mg/dl and 2.74 mg/dl, respectively.
The patient’s PCT levels spiked to 97.60 ng/ml, and anti-
biotics were switched to meropenem 1 g every 8 h, mox-
ifloxacin 400 mg once daily, and 200 mg fluconazole
twice daily. At that time, our patient received 1000 kcal/
500 ml of parenteral nutrition through intermittent
bolus nasogastric feeding tubes.
On the second day, the results of a wound culture re-
vealed the growth of Streptococcus pyogenes, and mero-
penem was changed to 400 mg of teicoplanin daily along
with moxifloxacin, based upon antibiotic sensitivity
results. Cultures from the patient’s blood and urine re-
vealed no growth, whereas a sputum culture revealed
growth of Candida albicans, and a fluconazole regimen
was resumed. The patient’s blood gas analysis normal-
ized with pH 7.38, pCO2 40.6 mmHg, pO2 138.8 mmHg,
HCO3
− 16.6 mEq/L, base excess −3.9 mEq/L, and serum
lactate 1.3 mmol/L. His blood pressure was stable at
110/50 mmHg (MAP 70 mmHg); his heart rate was
100–120 bpm with atrial fibrillation; and his CVP was
12 mmHg. Intravenous amiodarone at 150 mg for 10
minutes was given, followed by a continuous infusion of
150 mg for 12 h.
Wound debridement and necrotomy were performed
on the second day. However, 1 h postdebridement, the
patient’s blood pressure plummeted to 50/30 mmHg
(MAP 38) with a heart rate of 100 bpm. A bolus of 100
ml of normal saline was given along with noradrenaline
at 0.8 μg/kg/minute and epinephrine at 8 μg/kg/minute.
The amiodarone infusion was stopped. The patient’s vital
signs responded progressively, and epinephrine was
slowly tapered and then completely discontinued after 2
h. Maintenance fluids were given at 40 ml/h normal sa-
line with a total daily fluid input of 3850 ml, diuresis of
70 ml/h, and a daily fluid balance of +1255 ml.
On the third day, the patient’s mental status improved
dramatically; he was able to respond to instructions, and
his vital signs remained within normal limits. The venti-
lator mode and settings remained unchanged, and the
patient was actively triggering breaths with good ventila-
tor synchrony. A complete blood examination revealed
Hgb 9.9 g/dl (reference range 11.70–15.50 g/dl), Hct
24.5% (reference range 35.00–47.00%), WBC 24,190/
mm3 (reference range 3600–11,000/mm3), and a PCT
level decreasing to 83.46 ng/ml. His coagulation profile
revealed Plt 149,000/μl (reference range 150,000–
440,000/μl) with a prothrombin time (PT) of 13.60
seconds, international normalized ratio (INR) of 1.15, acti-
vated partial thromboplastin time (aPTT) of 55.40 seconds,
and D-dimer of 5.36 ng/ml. His urea decreased slightly to
151.7 mg/dl (reference range <50 mg/dl); his creatinine
was 1.84 mg/dl; and his serum albumin was 2.88 mg/dl
(reference range 3.5–5.3 mg/dl). Enteral nutrition was
resumed because no residual gastric fluid was noted, and
the maintenance fluid used was normal saline at 20 ml/h
with noradrenaline tapered to 0.01 μg/kg/minute. Total
daily fluid input was 2198 ml with diuresis of 91 ml/h and
a fluid balance of −967 ml.
On the fourth day, the vasopressor infusion was dis-
continued. The patient remained afebrile and responsive;
hence, weaning from mechanical ventilation was initi-
ated. His vital signs remained stable throughout the
weaning process, with a blood pressure of 110/70 mmHg
(MAP 83 mmHg), heart rate of 85–90 bpm, and CVP of
9 mmHg. His physical examination revealed clear lung
sounds confirmed by a clear chest x-ray, and the results
of his arterial blood gas analysis were within normal
limits. The maintenance fluid used was normal saline at
40 ml/h with a total daily fluid input of 2610 ml, diuresis
of 100 ml/h, and a fluid balance of −765 ml.
On the fifth day, the patient was extubated. His vital
signs remained stable 1 h postextubation with a respira-
tory rate of 18 breaths per minute and CVP of 10
mmHg, and his arterial blood gas analysis showed pH
7.428, pCO2 26.4 mmHg, pO2 173.1 mmHg, HCO3
−
−17.8 mEq/L, and base excess −5.1 mEq/L. A repeat
blood workup revealed Hgb 10.28 g/dl, Hct 31%, WBC
17,380/mm3, and Plt 114,000/μl. Other readings were
PT 14.60 seconds, INR 1.24, aPTT 43.80 seconds, and
Fig. 2 Chest x-ray taken on initial intensive care unit admission
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D-dimer 5.90. The patient’s urea level was 130.9 mg/dl,
and his creatinine level was 1.24 mg/dl. His nasogastric
tube was withdrawn, and he was started on oral feeding.
Normal saline was given at 20 ml/h with a total daily
fluid input of 2562 ml, diuresis of 148 ml/h, and a daily
fluid balance of −1998 ml (Fig. 3).
On the sixth day, he was discharged to the general ward.
Normal saline was given at 20 ml/h with a total daily fluid
input of 1858 ml, diuresis of 143 ml/h, and a daily fluid
balance of −2537 ml (Table 1). An order to complete his
10-day course of intravenous moxifloxacin and his 14-day
course of intravenous teicoplanin was completed, and he
was discharged to home after 10 days of care in the gen-
eral ward, without any negative sequelae.
Throughout his stay, our patient received metoclopra-
mide, proton pump inhibitors, and daily nebulized salbu-
tamol and mucolytic agents. Endotracheal suctioning was
carried out as needed through a closed system device.
Additionally, deep vein thrombosis prophylaxis was car-
ried out using compression stockings and an intermittent
pneumatic device. The wound site was cared for meticu-
lously with daily dressing changes, and healing progressed
significantly. Daily fluid balance was calculated by ac-
counting for fluid input as all fluids administered through
intravenous or nasogastric routes and metabolism prod-
ucts, which were one-third the value of insensible water
loss (325 ml/day). Fluid output was counted as fluids col-
lected from urine, wound drainage, nasogastric fluids, and
insensible water loss, which was calculated at 15% of body
weight in milliliters (975 ml/day) (Fig. 4).
Discussion
Necrotizing fasciitis is a rapid and progressive necrotiz-
ing process involving the subcutaneous fat, superficial
fascia, and superficial deep fascia [4]. The diagnosis of
necrotizing fasciitis in our patient was straightforward
because it had evolved from an infected peripheral intra-
venous catheter site. Intravenous broad-spectrum antibi-
otics were administered; nevertheless, the patient’s
phlebitis progressed to necrotizing fasciitis and to septic
shock as clinically evident by his deteriorating mental
status, hypotension, and decreased urine output.
As the patient’s sepsis progressed, he experienced re-
spiratory distress, which may have been a result of leaky
capillaries at the arterial-alveolar junction. Edema on al-
veolar cells changes their vital cell architecture because
less surface area is available for effective gas exchange
[5]. Impaired oxygenation, together with high oxygen re-
quirements during a stressful septic period, may divert
as much as 35–40% of blood flow to the diaphragm and
respiratory muscles to keep up with the necessary oxy-
gen demand [6]. Over time, ventilatory muscles fatigue
and are unable to maintain a physiological acid–base
status. Thus, a decision to intubate and provide mechan-
ical ventilation was made to supply adequate oxygenation
and ventilation while resting the patient’s ventilatory mus-
cles. Sedation and pain control are also important aspects
of care because they reduce anxiety, provide better
ventilator-patient synchrony, reduce oxygen demand, and
reduce the incidence of arrhythmias [7].
Throughout his septic period, the patient experienced
an episode of hypotension that was unresponsive to fluid
administration. With a massive “cytokine storm,” pro-
found vasodilation and capillary leak occur, resulting in
rapid fluid distribution into the interstitial space, thus
leaving the intravascular space devoid of effective circu-
lating volume and creating hypotension [4, 8]. Therefore,
fluid resuscitation at this stage has the role of filling the
Fig. 3 Daily mean arterial pressure and vasopressor dose. ICU Intensive care unit
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intravascular volume, but its effects are transient be-
cause leaky capillaries eventually deplete the intravascu-
lar volume once again. In fact, after 90 minutes, less
than 5% of infused fluid remains in the intravascular
compartment of patients with sepsis [9]. Consequently,
continuing with large-volume fluid administration with
the hope of achieving adequate blood pressure and
organ perfusion is associated with increased mortality.
In multiple studies of intravenous fluid resuscitation
using either early goal-directed therapy or standard care,
researchers have reported an average of more than 4 L
of fluid administered during the initial 6 h of resuscita-
tion [10–12], whereas fluid administered from 6 to 72 h
averaged more than 8 L [13]. Our patient had received a
total of 4 L of crystalloid infusion within 20 h in addition
to 600 ml of bolus colloid infusion during his
hypotensive episode. Nevertheless, his MAP remained
inadequate, and 0.8 μg/kg/minute noradrenaline was re-
quired to meet an MAP above 65 mmHg. Additionally,
his urine output had been less than 1 ml/kg/h for the
previous 20 h along with a rising trend in serum
creatinine.
At this point, the clinician needs to be wary in institut-
ing further fluids because doing so will increase edema,
especially to organs such as the liver and kidney. With
progressive capillary leak, these encapsulated organs are
unable to compensate for the increased volume, and se-
vere interstitial edema will compress vital blood flow
[14]. Aside from compression, increased edema leads to
microvascular flow congestion and sluggish peritubular
flow, as evidenced by our patient’s abrupt renal failure
and positive fluid balance [15]. Hence, the use of early
vasopressors is critical to maintaining an effective MAP
necessary for adequate organ perfusion and to limiting
edema formation [16].
We believe fluid therapy is best tailored to specific in-
dications and that the administration of aggressive fluid
administration should be restricted only to the resuscita-
tion phase of septic shock. Hoste et al. best summed up


















Blood pressure, mmHg 60/30 115/60 110/50 50/30 116/60 110/70 116/75 120/70
Heart rate, beats/minute 140 120 120 (atrial
fibrillation)
100 95 90 85 80
Mean arterial pressure,
mmHg
40 78 70 38 79 83 89 87
Respiratory rate, breaths/
minute
38 30 20–25 40–45 15–18 16–20 18 16
Central venous pressure,
mmHg
18 12 12 12 10 9 9 8









0.5 0.8 0.15 0.8 0.01 None None None
Epinephrine, μg/kg/minute None None None 8 (titrated and
discontinued
after 2 h)
None None None None
Dobutamine, μg/kg/minute 10 3 3 None None None None None
Fluids 20 h 4 h 24 h 24 h 24 h 24 h 24 h
Input, ml 4644 100 3850 2198 2610 2562 1858
Urine output, ml/h 55 20 70 91 100 148 143
Fluid balance, ml +3540 +34 +1255 −967 −765 −1998 −2537
HCU High-care unit, ICU Intensive care unit
Fig. 4 Daily fluid balance
Hariyanto et al. Journal of Medical Case Reports  (2017) 11:30 Page 5 of 7
the four stages of fluid therapy as divided into resuscita-
tion, optimization, stabilization, and evacuation phases
[17]. Our patient’s resuscitation phase began from day 1
of HCU care, when 4 L of normal saline were adminis-
tered. As his hemodynamic status began to deteriorate,
another 500 ml of colloid and 100 ml of 20% albumin
were administered along with vasopressors to avoid hy-
poperfusion and correct uncompensated shock.
After the patient’s shock was managed, he entered the
optimization phase, which is a state of compensated
shock. At this phase, giving too little fluid will cause the
patient to fall back into a shocked state, whereas giving
too much fluid will cause inadvertent fluid overload [17].
Consequently, our patient was managed with 60 ml/h of
fluid and vasopressor. After the optimization phase for 6
h in the ICU, repeat blood work revealed decreasing
serum lactate and improving capillary refill time. However,
it is noteworthy that increased lactate during sepsis is not
a marker of tissue hypoxia, because lactate is produced as
a result of adrenergic and inflammatory responses [18].
Hence, decreasing lactate in our patient marked the
downregulation of the host inflammatory response,
whereas improving capillary refill time and increasing
urine output indicated improving organ perfusion.
Next comes the stabilization phase, which is the period
when fluids are administered to provide daily require-
ments and replace ongoing losses, if any [3]. The Fluid
and Catheter Treatment Trial (FACTT) researchers re-
ported better outcomes for those patients who were
treated using conservative fluid regimens than for those
who received the usual “maintenance” fluids with liberal
fluid management [19]. In this trial, patients who were
treated with liberal fluid received an average of more
than 4 L/day, as compared with those who underwent a
conservative fluid regimen, who received 3.5 L/day, over
the first week. Our patient received an average of 2.9 L/
day, amounting from a normal saline infusion at 20–40
ml/h in addition to enteral nutrition and infusions of
sedative, analgesic, antimicrobial, and vasoactive drugs.
In the evacuation phase of fluid therapy, fluids are de-
liberately removed from the patient, and the goal is to
strive for a negative fluid balance [17]. In our patient,
negative fluid balance was achieved through diuresis
alone, without any drug intervention. Because his condi-
tion improved with appropriate antimicrobial therapy
and a conservative fluid regimen, his renal function
gradually improved by increasing urine output and sub-
sequent lowering of urea and creatinine levels. However,
at some point, the evacuation phase may involve the use
of diuretics or renal replacement therapy with the goal
of mobilizing excess fluid from the body.
Source control through wound debridement and
necrotomy was performed, and 1 h postdebridement our
patient experienced sudden hypotension that may have
been due to toxic shock syndrome. Toxins liberated
from Streptococcus during surgery spark an immuno-
logical response followed by massive release of histamine
into the circulation, and they produce marked
hypotension [4]. A bolus of 100 ml of normal saline was
administered to rapidly fill the depleted intravascular
volume, together with the institution of noradrenaline
and epinephrine. The patient’s vital signs progressively
stabilized, and within 2 h the epinephrine infusion was
discontinued. Broad-spectrum antiobiotic therapy using
meropenem, moxifloxacin, and fluconazole was adminis-
tered while awaiting the results of culture and antibiotic
sensitivity tests, which later revealed sensitivity to teico-
planin and moxifloxacin. Hence, both teicoplanin and
moxifloxacin were administered starting on day 2 of
ICU care, along with fluconazole because his sputum
culture revealed growth of Candida albicans.
Another variable commonly sought in the management
of patients with sepsis is the CVP. Throughout our pa-
tient’s care, his CVP value was not used as a guide in ti-
trating fluid administration, because this method has been
proven to be an unreliable method of measuring overall
volume status. The heart and systemic vasculature is a
complex system that functions together in preserving ef-
fective circulating volume by mobilizing fluids through
vasoconstriction, vasodilation, or increasing cardiac out-
put [20]. The response is dynamic and continually adapt-
ing at a rapid rate; thus, measuring static CVP at one
point in the day to assess overall fluid status is inaccurate
and ill-advised. In fact, values of CVP as well as intramural
and pulmonary arterial occlusion pressure have been
proven to have no correlation with circulating blood
volume [21].
Aside from fluid input, an important aspect of improv-
ing clinical outcomes of patients with sepsis is to keep a
watchful eye on their fluid balance. Cumulative fluid bal-
ance reported by critically ill nonsurvivors averaged 7761
± 7391.9 ml for 1 week [2]. Our patient had a positive
fluid balance during the first and second days of his ICU
stay (+3540 ml and +1255 ml, respectively); nevertheless,
he had a negative fluid balance on the following 4 days
(−967 ml, −765 ml, −1998 ml, and −2537 ml, respectively)
with a cumulative fluid balance of −1472 ml for 7 days in
the ICU. His renal function improved; his mentation sub-
stantially improved; his respiratory distress quickly re-
solved; and his vasopressors were discontinued.
Throughout his ICU stay, our patient received normal
saline and additional fluids from enteral nutrition at
1000 kcal/500 ml, which were given as intermittent 100-
ml bolus feedings. Deep vein thrombosis prophylaxis
was achieved through mechanical compression because
thrombocytopenia, coagulopathy, and elevated D-dimer
levels herald the development of disseminated intravas-
cular coagulation and heparin was of limited use. Passive
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physiotherapy was initiated early to prevent muscle atro-
phy and stiffness, whereas active physiotherapy followed
after the patient responded [22]. Bronchial hygiene and
pulmonary toilet were exercised with daily mucolytic
nebulizers, and suction was provided through a closed
system device.
Conclusions
Current evidence on fluids and sepsis urges us to reconsider
the fluid regimen in the management of patients with sepsis
because aggressive fluid administration after a state of resus-
citated sepsis is well-documented to have the worst out-
come. Patients with sepsis respond poorly to fluids because
a massive and erratic cytokine storm results in arterioveno-
dilation and microcirculatory dysfunction during the early
stages of septic shock; hence, fluid administered during the
resuscitation phase is best given with vasopressors and early.
After this phase, fluids must be tapered to prevent inadvert-
ent fluid overload, which will worsen oxygen transport at
the cellular level. Successful management of sepsis requires
an integrated approach of infection control, use of appropri-
ate antimicrobials, and supportive care. But perhaps every
clinician ought to be extra vigilant in prescribing the most





Availability of data and material
Please contact Hori Hariyanto for data requests.
Authors’ contributions
HH, PW, and OET contributed to making the diagnosis of and devising the
treatment strategy for this patient. CQY, MW, and HH conceived of and
wrote this report and coordinated in drafting the manuscript. All authors
read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient’s next of kin for
publication of this case report and any accompanying images. A copy of the
written consent is available for review by the Editor-in-Chief of this journal.
Ethics approval and consent to participate
Not applicable.
Author details
1Department of Anesthesiology and Critical Care Medicine, 3rd floor, Siloam
Hospitals Lippo Village, Jalan Siloam No. 6, Karawaci, 15811 Tangerang,
Banten, Indonesia. 2Department of Anesthesiology, Faculty of Medicine,
Universitas Pelita Harapan, Jalan Boulevard Jendral Sudirman, Lippo Karawaci,
Tangerang 15811, Indonesia.
Received: 28 October 2016 Accepted: 27 December 2016
References
1. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al.
Surviving Sepsis Campaign guidelines for management of severe sepsis and
septic shock. Crit Care Med. 2004;32(3):858–73.
2. Malbrain ML, Marik PE, Witters I, Cordemans C, Kirkpatrick AW, Roberts DJ,
et al. Fluid overload, de-resuscitation, and outcomes in critically ill or injured
patients: a systematic review with suggestions for clinical practice.
Anaesthesiol Intensive Ther. 2014;46(5):361–80.
3. Hoste EA, Maitland K, Brudney CS, Mehta R, Vincent JL, Yates D, et al. Four
phases of intravenous fluid therapy: a conceptual model. Br J Anaesth. 2014;
113(5):740–7.
4. Johansson L, Thulin P, Low DE, Norrby-Teglund A. Getting under the skin:
the immunopathogenesis of Streptococcus pyogenes deep tissue infections.
Clin Infect Dis. 2010;51(1):58–65.
5. Pierrakos C, Karanikolas M, Scolletta S, Karamouzos V, Velissaris D. Acute
respiratory distress syndrome: pathophysiology and therapeutic options. J
Clin Med Res. 2012;4(1):7–16.
6. Otis AB. The work of breathing. Physiol Rev. 1954;34(3):449–58.
7. Patel SB, Kress JP. Sedation and analgesia in the mechanically ventilated
patient. Am J Respir Crit Care Med. 2012;185(5):486–97.
8. Nunes TSO, Ladeira RT, Bafi AT, de Azevedo LCP, Machado FR, Freitas FGR.
Duration of hemodynamic effects of crystalloids in patients with circulatory
shock after initial resuscitation. Ann Intensive Care. 2014;4:25. doi:10.1186/
s13613-014-0025-9.
9. Sanchez M, Jimenez-Lendinez M, Cidoncha M, Asensio MJ, Herrerot E,
Collado A, et al. Comparison of fluid compartments and fluid
responsiveness in septic and non-septic patients. Anaesth Intensive Care.
2011;39(6):1022–9.
10. The ProCESS Investigators. A randomized trial of protocol-based care for
early septic shock. N Engl J Med. 2014;370(18):1683–93.
11. Delaney AP, Peake SL, Bellomo R, Cameron P, Holdgate A, Howe B, et al.
The Australasian Resuscitation in Sepsis Evaluation (ARISE) trial statistical
analysis plan. Crit Care Resusc. 2013;15(3):162–71.
12. Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD,
et al. Protocolised Management In Sepsis (ProMISe): a multicentre
randomised controlled trial of the clinical effectiveness and cost-
effectiveness of early, goal-directed, protocolised resuscitation for emerging
septic shock. Health Technol Assess. 2015;19(97).
13. Nguyen HB, Jaehne AK, Jayaprakash N, Semler MW, Hegab S, Yataco AC,
et al. Early goal-directed therapy in severe sepsis and septic shock: insights
and comparisons to ProCESS, ProMISe, and ARISE. Crit Care. 2016;20(1):160.
14. Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and
acute kidney injury. Nat Rev Nephrol. 2010;6(2):107–15.
15. Legrand M, Dupuis C, Simon C, Gayat E, Mateo J, Lukaszewicz AC, et al.
Association between systemic hemodynamics and septic acute kidney
injury in critically ill patients: a retrospective observational study. Crit Care.
2013;17(6):R278.
16. Bai X, Yu W, Ji W, Lin Z, Tan S, Duan K, et al. Early versus delayed
administration of norepinephrine in patients with septic shock. Crit Care.
2014;18(5):532.
17. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression:
from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;
13(12):862–74.
18. Marik PE, Bellomo R, Demla V. Lactate clearance as a target of therapy in
sepsis: a flawed paradigm. OA Crit Care. 2013;1(1):3.
19. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome
(ARDS) Clinical Trials Network. Comparison of two fluid-management strategies
in acute lung injury. N Engl J Med. 2006;354(24):2564–75.
20. Gelman S. Venous function and central venous pressure: a physiologic story.
Anesthesiology. 2008;108(4):735–48.
21. Oohashi S, Endoh H. Does central venous pressure or pulmonary capillary
wedge pressure reflect the status of circulating blood volume in patients
after extended transthoracic esophagectomy? J Anesth. 2005;19(1):21–5.
22. Sommers J, Engelbert RH, Dettling-Ihnenfeldt D, Gosselink R, Spronk PE,
Nollet F, et al. Physiotherapy in the intensive care unit: an evidence-based,
expert driven, practical statement and rehabilitation recommendations. Clin
Rehabil. 2015;29(11):1051–63.
Hariyanto et al. Journal of Medical Case Reports  (2017) 11:30 Page 7 of 7
